Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Linda Palczuk Insider Profile
4 Followers
Linda Palczuk, President & CEO at Osiris Therapeutics Inc, holds ― shares in Osiris Therapeutics Inc (Ticker: OSIR), holds 66.40K shares in Avadel Pharmaceuticals (Ticker: AVDL), holds 8.50K shares in Verrica Pharmaceuticals (Ticker: VRCA). Most recently, Linda Palczuk ― shares of Osiris Therapeutics Inc on ― for an estimated value of ―.
Linda Palczuk Osiris Therapeutics Inc (OSIR)President & CEO
Osiris Therapeutics Inc (OSIR)
President & CEO
Ranked #1,527 out of 99,797 Corporate Insiders
Profitable Transactions
4 out of 6 Profitable Transactions
Average Return
+108.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Linda Palczuk holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 31, 2022 - May 31, 2023
Return:+526.60%
The most profitable trade made by Linda Palczuk
Linda Palczuk's Trading History
Osiris Therapeutics Inc
―
―
―
―
Avadel Pharmaceuticals
Dec 10, 2024
Director
Informative Buy
30.54K
$684.58K
Verrica Pharmaceuticals
Jan 17, 2019
COO
Informative Buy
31.59K
$5.90K
List of latest transactions for each holding click on a transaction to see Linda Palczuk's performance on stock
You May Also Like
Linda Palczuk insider profile FAQ
What is the percentage of profitable transactions made by Linda Palczuk?
The percentage of profitable transactions made by Linda Palczuk is 67%.
What is the average return per transaction made by Linda Palczuk?
The average return per transaction made by Linda Palczuk is 108.40%.
What stocks does Linda Palczuk hold?
Linda Palczuk holds: OSIR, AVDL, VRCA stocks.
What was Linda Palczuk’s latest transaction?
Linda Palczuk latest transaction was an Uninformative Buy of ―.
What was Linda Palczuk's most profitable transaction?
Linda Palczuk’s most profitable transaction was an Informative Buy of AVDL stock on May 31, 2022. The return on the trade was 526.60%.
What is Linda Palczuk's role in Osiris Therapeutics Inc?
Linda Palczuk's role in Osiris Therapeutics Inc is President & CEO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.